# A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder

> **NCT03078270** · PHASE4 · TERMINATED · sponsor: **Daniel Lieberman** · enrollment: 4 (actual)

## Conditions studied

- Anxiety Disorder Social
- Anxiety

## Interventions

- **DRUG:** botulinum toxin A
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03078270
- **Lead sponsor:** Daniel Lieberman
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-01
- **Primary completion:** 2017-09-12
- **Final completion:** 2017-09-12
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** study terminated due to low recruitment
- **Last updated:** 2019-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03078270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03078270, "A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03078270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*